Cost-effectiveness of novel multiple sclerosis drug
Third-party funded project
Project title Cost-effectiveness of novel multiple sclerosis drug
Principal Investigator(s) Schwenkglenks, Matthias
Co-Investigator(s) Szucs, Thomas
Project Members Bhadhuri, Arjun
Schur, Nadine
Organisation / Research unit Departement Public Health / Pharmazeutische Medizin (Szucs)
Project start 10.12.2018
Probable end 31.12.2019
Status Completed
Abstract

Assessment of cost-effectiveness of a novel multiple sclerosis drug, from the perspective of the Swiss statutory health insurance and Swiss healthcare system.

Financed by Private Sector / Industry
   

MCSS v5.8 PRO. 0.458 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
14/08/2020